BloodSTOP® is a natural, biocompatible, non-irritating, animal-free material that adheres to a wound, absorbs blood, stops bleeding, and forms a protective layer to create an environment for wound healing. Its water solubility allows it to be rinsed off without disruption to the clotted surface.
Vicky Feng, Chief Executive Officer and President
Vicky Feng founded LifeScience PLUS with a vision for next-generation medical products that aid medical professionals in administering care while improving patient recovery. She brings 16 years of computer industry and 12 years of medical industry entrepreneurial and management experience to the Company, guiding startups and maturing them into fully profitable enterprises. One of her earliest ventures was in the PC industry where she was on the founding team and grew the company to $10 million in annual revenues in 3 years. Ms. Feng holds a B.S. degree in Electrical Engineering from Beijing United University.
Juan N. Walterspiel, MD, FAAP, Chief Scientific and Medical Officer
Dr. Walterspiel has over 21 years of experience in the Biotech and Pharmaceutical industries. He has served as the International Clinical Leader at Hoffman La Roche/Genentech, International Medical Director at Pfizer and Chief of Medical Affairs and Regulatory at Inhibitex. Dr. Walterspiel's contributions while Chief Medical Officer for GeneOhm led to the company’s acquisition by Becton Dickinson. Since serving in these positions, he has been a clinical development consultant for many large pharmaceutical companies and numerous startup companies.
In addition to his experience in industry, Dr. Walterspiel was an attending and teaching physician for 25 years, and still maintains Board Certification in Pediatrics. His academic career includes successive faculty positions at the University of Texas Medical School in Houston, TX and Yale Medical School in New Haven, CT. Dr. Walterspiel has authored over 40 publications and several book chapters. His research interests are broad and range from infections to sepsis (inflammatory response syndrome) to coagulation. He is a member of the IDSA, ASM, AAP, PIDS and ACRP and has served(s) on several professional committees.
Marty Miller, Chief Marketing and Sales Officer
Marty Miller is a classically trained, recognized and proven product marketing executive with over 25 years of global sales and marketing leadership experience. Ms. Miller has lead tightly focused, integrated marketing around the world for revolutionary products in top-pedigree companies, developing inspirational brands with ubiquitous products at companies such as NeXT - working directly with Steve Jobs - and Apple and IBM. Her elite methodology smoothly weaves compelling marketing into dynamic direct sales and fluid partner sales, creating value and building brand recognition along with fast-paced sales growth. Using her time-tested formula for forging partnerships in market-defining global technology companies, she successfully establishes, customizes and scales complex businesses from the ground up to over $500 million in revenue in 4 to 5 years, serving consumer and vertical enterprise markets, including medicine and healthcare. Ms. Miller graduated Cum Laude from Tufts University studying International Relations and German, and completed advanced coursework in global sustainable Health Delivery and Nutrition. She serves as a Director and counselor on several philanthropy Boards, offering her executive expertise to develop sustainable and socially responsible practices elevating humanitarian projects around the world.
Dozier Jones, Vice President of Operations
Dozier Jones has over 30 years experience in executive sales and executive sales management in the automotive and scientific products industries where he was well known for his ability to train and develop strong effective sales teams while building strong customer and supplier business relationships. He spent 26 years in the scientific products and cleanroom supplies distribution business, managing sales teams and contractual relationships with medium to very large life sciences and microelectronics customers. Mr. Jones has held senior sales management positions with major distribution companies including American Hospital Supply Corporation, Baxter Scientific Products, Paxxis, Inc. and VWR International, where as Senior Vice President, Western Area, he lead his team to sales of over $215 million. Mr. Jones spent 10 years with the Lincoln-Mercury Division of Ford Motor Company in field sales and sales management directing the marking and wholesale of Lincoln-Mercury vehicles. He has received numerous first-place national awards for his sales teams’ performance. Mr. Jones served in the United States Marine Corps where he achieved the rank of Captain after five years of service. He is a Vietnam Veteran and received the Bronze Star (with Combat V) and the Vietnam Cross of Gallantry (with Bronze Star) for combat service. Mr. Jones has a B.S. in Business Administration from the University of Dubuque in Dubuque, Iowa, where he had a successful three-sport athletic career including earning four letters in football. He earned All-Iowa Conference honors as both a defensive lineman and linebacker, was selected as a Little All-American and was named to the All-Iowa Conference N.A.I.A. Football Team. Mr. Jones was inducted into the University of Dubuque Athletic Hall of Fame in 2004.
James Hagen, Director of Medical Sales and Marketing
Mr. Hagen has over 20 years experience in sales and marketing of medical products with an emphasis on Hospital and GPO markets. Jim has developed projects from the ground up for Medtronic, General Electric Medical, and Gyrus Medical. Working within the small hospital division of General Electric Medical, Jim brought the Southern California region from a zero dollar enterprise to a million dollar plus annual business. He has actively participated in the introduction and development of electronic and instrumentation projects, from multichannel EMG to Plasma Knife implementation. As the Western Regional Sales Trainer for Medtronic, and later for Gyrus Medical, Jim trained and managed groups from the Midwest to the Pacific Coast with an emphasis on product introduction strategies that incorporate multimedia customer contact and high closure rate techniques. Jim's experience includes direct commission sales, sales training, sales management, and ground-up new product development. His undergrad and post-grad education at Oregon State in Pre-med and Medicine have helped to shape his academic approach. His participation in Division 1 athletics and multiple All-America awards have shaped his competitive attitude.
Audrey Vitale, Director of Regulatory Affairs
Ms. Vitale has 14 years of experience in medical device regulation, including product approvals in the US and EU, and quality system compliance with ISO 9001, ISO 13485, EU Medical Device Directive, and FDA Quality System Regulation. Ms. Vitale jointed LifeScience PLUS after 9 years as Regulatory Affairs Director for Ultracell Medical Technologies, an ophthalmology and ENT device manufacturer, where she was responsible for regulatory affiars, quality assurance, product and manufacturing validation, and quality system development and compliance. Prior to working in the medical device field, Ms. Vitale was a process engineer for Corning, Inc. in their optical fiber manufacturing division. Ms. Vitale has a B.S. in Materials Engineering from Rensselaer Polytechnic Institute, and is a member of the Regulatory Affairs Professional Society, with certification in US Regulatory Affairs.
Patrick Lin, Business Advisor
Patrick Lin has over 18 years of senior-level experience in US and China related investment management and equity capital markets, conducting over 1,500 public company management meetings and leading or co-managing over 250 equity capital offerings. Since 2002 he has been Portfolio Manager and Chief Investment Officer of Primarius Capital, an investment firm with holdings in technology, healthcare, consumer, and China-related sectors. Primarius has been one of the earliest investors in SINA Corp (leading Internet and Weibo company in China) and Questcor (emerging pharmaceutical company). While at Primarius he has been responsible for all aspects of the company's growth and operations, and launched one of the earliest China-focused hedge funds in the US. Mr. Lin was a co-founding partner of E*Offering, the investment bank of E*Trade, serving as Managing Director, Equity Capital Markets, and Executive Committee member. E*Offering was involved in over 100 public offerings in its first 15 months of operations (1 out of 2 internet IPOs) and was acquired by Wit Capital for $328M in 2000. Prior to E*Offering, Mr. Lin was a Principal in Institutional Research Sales at Robertson Stephens & Co., playing a significant role in many of the firm's successful IPOs of multi-billion dollar market cap companies, and developing the firm's MBA recruiting program during a period of rapid company growth. Mr. Lin holds an MBA from Kellogg Graduate School of Management and a Bachelor of Science in Business Administration from the University of Southern California.
Board of Directors
Vicky Feng, Chairman
Vicky Feng founded LifeScience PLUS with a vision for next-generation medical products that aid medical professionals in administering care while improving patient recovery. Serving as Chief Executive Officer and President, she brings 12 years of medical and 16 years of computer industry entrepreneurial and management experience to the Company, guiding startups and maturing them into fully profitable enterprises. One of her earliest ventures was in the PC industry where she was on the founding team and grew the company to $10 million in annual revenues in 3 years. Ms. Feng holds a B.S. degree in Electrical Engineering from Beijing United University.
David Young, Pharm.D., Ph.D.
Dr. Young joined the LSP Board of Directors in June of 2012. He is currently the CSO of Questcor Pharmaceuticals, a position he's held since October 2009. Prior to that, Dr. Young served as Executive Director & President, U.S. Operations of AGI Therapeutics plc since 2006. Previous to 2006, Dr. Young was the Executive Vice President of the Strategic Drug Development Division of ICON plc, an international CRO, and founder and CEO of GloboMax LLC, a contract drug development firm purchased by ICON plc in 2003. Prior to forming GloboMax, Dr. Young was an Associate Professor at the School of Pharmacy, University of Maryland-VA Clinical Research Unit. Dr. Young has represented more than 30 sponsors at the Food and Drug Administration (FDA), worked on more than 70 drug products, and been involved with more than 30 NDA submissions. Dr. Young has an extensive background in drug development that includes more than 150 presentations and authored publications, including formal presentations to the FDA and numerous invited presentations at scientific meetings. Dr. Young is an expert in 505(b)(2) drug development, having worked on more than 25 programs in various therapeutic areas including Central Nervous System diseases and disorders.
Dr. Kenneth Robinson, DMD MS
Dr. Robinson taught oral and maxillofacial surgery at Tufts University before beginning his private practice. He has been in private practice for thirty three years. He has been honored as a Board Diplomat, American Board of Oral Surgery; Fellow, American Dental Society of Anesthesiology; Fellow, American Association of Oral and Maxillofacial Surgeons and a Diplomat of the National Dental Board of Anesthesiology. Dr. Robinson has authored publications in scientific journals. He holds a DMD degree from the University of Pennsylvania and a MS in pharmacology from the University of Rochester.
James Little, Esquire
James Little has forty-five years of experience practicing corporate law during which time he has represented private business concerns throughout Silicon Valley. He has focused his firm’s practice on the formation and legal representation of growth companies. Mr. Little is a graduate of Harvard College and Stanford Law School.